Likelihood ratios for genome medicine

Patients are beginning to present to healthcare providers with the results of high-throughput individualized genotyping, and interpreting these results in the context of the explosive growth of literature linking individual variants with disease may seem daunting. However, we suggest that results of a personal genomic analysis may be viewed as a panel of many tests for multiple diseases. By using well-established methods of evidence based medicine, these very many parallel tests may be combined using likelihood ratios to report a post-test probability of disease for use in patient assessment.

[1]  Dmitry Pushkarev,et al.  Single-molecule sequencing of an individual human genome , 2009, Nature Biotechnology.

[2]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[3]  J. Carpten,et al.  Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. , 2007, Journal of the National Cancer Institute.

[4]  J. Kassirer,et al.  Learning Clinical Reasoning , 1991 .

[5]  P. Stankiewicz,et al.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. , 2010, The New England journal of medicine.

[6]  N. Hawkins,et al.  Ethical implications of the use of whole genome methods in medical research , 2009, European Journal of Human Genetics.

[7]  Peter Kraft,et al.  Curses--winner's and otherwise--in genetic epidemiology. , 2008, Epidemiology.

[8]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[9]  Thomas D. Wu,et al.  A highly annotated whole-genome sequence of a Korean individual , 2009, Nature.

[10]  R. Altman,et al.  The incidentalome: a threat to genomic medicine. , 2006, JAMA.

[11]  K. Frazer,et al.  Human genetic variation and its contribution to complex traits , 2009, Nature Reviews Genetics.

[12]  G H Guyatt,et al.  Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence-Based Medicine Working Group. , 1999, JAMA.

[13]  J. Pritchard,et al.  Overcoming the winner's curse: estimating penetrance parameters from case-control data. , 2007, American journal of human genetics.

[14]  M. Khoury,et al.  A navigator for human genome epidemiology , 2008, Nature Genetics.

[15]  J. Ioannidis,et al.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement , 2009, European Journal of Epidemiology.

[16]  Fagan Tj.  Letter: Nomogram for Bayes theorem. , 1975 .

[17]  Timothy B. Stockwell,et al.  The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.

[18]  J. Ioannidis.  Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.

[19]  T. Lumley,et al.  Potential for revealing individual-level information in genome-wide association studies. , 2010, JAMA.

[20]  Michael E Goddard,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Multi-locus models of genetic risk of disease , 2009 .

[21]  Adam S. Cifu,et al.  Symptom to Diagnosis: An Evidence-Based Guide , 2006 .

[22]  D. Goldstein.  Common genetic variation and human traits. , 2009, The New England journal of medicine.

[23]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[24]  A. Barton,et al.  Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23 , 2009, Human molecular genetics.

[25]  T. J. Fagan,et al.  Nomogram for Bayes's theorem , 1975 .

[26]  R. Prentice,et al.  Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. , 2008, Biostatistics.

[27]  Alexander A. Morgan,et al.  Clinical assessment incorporating a personal genome , 2010, The Lancet.